Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 31 of 38
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Drugmaker GSK to cut 650 jobs in US

GSK recently revealed its target of generating annual cost savings of £400m by 2021 by implementing the restructuring program across the group. The restructuring program was taken up